Woodward Pharma Services LLC, a Michigan-based specialty pharmaceutical organization, today announced an association with Indigene, an innovation-driven medical care solutions provider for the support of AcipHex (rabeprazole sodium delayed release tablets).
AcipHex is a proton-pump inhibitor (PPI) that works by decreasing gastric acid emission and is indicated for the treatment of gastroesophageal reflux infection (GERD), affecting up to 20% of adults in the United States. It is also used to treat duodenal ulcers and, in combination with antibiotics, to treat Helicobacter pylori (H. Pylori), a bacterial infection in the stomach.
Woodward chose Indigene for its profound medical expertise, adaptable and capital-efficient business model, and centers of excellence that have delivered significant results. Woodward will utilize Indigene’s advanced omni-channel capabilities, powered by cutting-edge artificial intelligence and machine learning, to enhance product awareness and engagement. Indigene will lead strategic brand planning and execution for Woodward, leveraging insights from over 1.8 million US healthcare professionals (HCPs) to promote and manage the brand through digital channels.
The President of Woodward stated, "We have been closely working with Indigene's team for the past few months and are excited about the novel capabilities and omni-channel expertise they bring. For more than 20 years, AcipHex has played a significant role in serving the needs of patients prescribed PPIs. By using the latest AI-driven solutions, Indigene will help educate consumers and healthcare professionals about the benefits and value of AcipHex, including a co-pay program."
The SVP of Indigene Emerging Biotech said, "We are delighted to contribute to Woodward's mission to better serve patients and offer exceptional value and customer experience. Increasingly, life sciences brands are engaging healthcare professionals through a digital-first omni-channel approach, and Woodward's initiative is a strong step in this direction. We are honored to be part of Woodward's business and marketing acceleration."
No comments:
Post a Comment